Cabometyx 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FHJU8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,822
Award facts
- Contract value 100% obligated
- $16,822.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,822.18 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count). The award, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, carries firm fixed-price terms and no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense healthcare operations.
DMS Pharmaceutical Group holds a single-award IDC under the PPV-G GEN V program with a ceiling value of $499,999,999 and completion date of December 31, 2036, positioning the company as a regional prime vendor contractor capable of supplying a comprehensive range of pharmaceuticals and medical consumables to military healthcare facilities worldwide. The contractor has demonstrated substantial federal contracting activity across multiple therapeutic categories, including oncology treatments, biologics, vaccines, and specialty pharmaceuticals, with no identified subcontractor relationships. The Cabometyx delivery order exemplifies the company's role as a critical supplier within the Department of Defense's pharmaceutical supply chain, supporting recurring medical supply needs across the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FHJU8?
SPE2DR26FHJU8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26FHJU8 worth?
The government has obligated $16,822 on SPE2DR26FHJU8.
Is contract SPE2DR26FHJU8 an order under another contract?
Yes. SPE2DR26FHJU8 is a delivery order under SPE2DR25D9218, an indefinite delivery contract.
Was contract SPE2DR26FHJU8 competed?
The extent of competition for SPE2DR26FHJU8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award